CHAD HODGE: Open Payments
NPI 1154854255 · LAKE CHARLES, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,400 in 124 payments from 12 companies in 2025. Trend: 2023 $2,463 · 2024 $2,134 · 2025 $2,400
Food & beverage: $2,382Education: $17
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 35 | $604 |
| AstraZeneca Pharmaceuticals LP | 22 | $410 |
| Regeneron Healthcare Solutions, Inc. | 11 | $274 |
| Viatris Specialty LLC | 16 | $271 |
| GENZYME CORPORATION | 13 | $256 |
| CSL Behring | 8 | $194 |
| Amgen Inc. | 4 | $98 |
| Verona Pharma, Inc. | 5 | $92 |
| Insmed, Inc. | 4 | $78 |
| Baxter Healthcare | 3 | $54 |
Products named: DUPIXENT, NUCALA, YUPELRI, Hizentra, BREZTRI, TEZSPIRE, TRELEGY ELLIPTA, FASENRA.
Industry payments across LA — which companies pay providers there.
